|
US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
US5972929A
(en)
*
|
1997-08-21 |
1999-10-26 |
Shiseido Co., Ltd. |
Quinazolinone derivative, hair growth promoter and external composition for skin using the same
|
|
EP1216243A1
(en)
|
1999-10-01 |
2002-06-26 |
Advanced Medicine, Inc. |
Quinazolinones and analogues and their use as local anesthetics
|
|
MXPA02010618A
(es)
*
|
2000-04-25 |
2004-05-05 |
Icos Corp |
Inhibidores de fosfatidilinositol 3-quinasa delta.
|
|
US6667300B2
(en)
*
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
ATE469648T1
(de)
|
2001-09-05 |
2010-06-15 |
Minerva Biotechnologies Corp |
Zusammensetzungen und deren verwendung zur behandlung von krebs
|
|
US20030119834A1
(en)
*
|
2001-09-05 |
2003-06-26 |
Bamdad Cynthia C. |
Compositions and methods of treatment of cancer
|
|
EP1444209A4
(en)
*
|
2001-11-07 |
2005-02-16 |
Merck & Co Inc |
INHIBITORS OF MITOTIC KINESINS
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
AU2003262747A1
(en)
*
|
2002-08-21 |
2004-03-11 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
AU2003291761A1
(en)
*
|
2002-11-04 |
2004-06-07 |
Nps Pharmaceuticals, Inc. |
Quinazolinone compounds as calcilytics
|
|
EP1646615B1
(en)
*
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
WO2005016348A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
|
WO2005016349A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methods of inhibiting leukocyte accumulation
|
|
PL1761540T3
(pl)
|
2004-05-13 |
2017-06-30 |
Icos Corporation |
Chinazolinony jako inhibitory ludzkiej kinazy 3-fosfatydyloinozytolu delta
|
|
JP2008500338A
(ja)
*
|
2004-05-25 |
2008-01-10 |
イコス・コーポレイション |
造血細胞の異常増殖を治療及び／又は予防する方法
|
|
EP1885356A2
(en)
*
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
EP2233472B1
(en)
*
|
2006-03-28 |
2014-01-15 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
NZ631024A
(en)
|
2008-11-13 |
2016-04-29 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
SG174529A1
(en)
|
2009-03-24 |
2011-10-28 |
Gilead Calistoga Llc |
Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
|
PT2421536E
(pt)
*
|
2009-04-20 |
2015-10-20 |
Gilead Calistoga Llc |
Métodos de tratamento para tumores sólidos
|
|
EP2456443A1
(en)
|
2009-07-21 |
2012-05-30 |
Gilead Calistoga LLC |
Treatment of liver disorders with pi3k inhibitors
|
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
|
WO2012140642A1
(en)
|
2011-04-10 |
2012-10-18 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
AP2014007875A0
(en)
|
2012-03-05 |
2014-08-31 |
Gilead Calistoga Llc |
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
|
|
IN2015MN00002A
(enExample)
|
2012-07-09 |
2015-10-16 |
Lupin Ltd |
|
|
PT3083630T
(pt)
|
2013-12-20 |
2019-11-15 |
Gilead Calistoga Llc |
Procedimentos para inibidores da fosfatidilinositol 3-quinase
|
|
EP3083623A1
(en)
|
2013-12-20 |
2016-10-26 |
Gilead Calistoga LLC |
Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
|
|
JP6455995B2
(ja)
|
2014-06-13 |
2019-01-23 |
ギリアード サイエンシーズ， インコーポレイテッド |
ホスファチジルイノシトール３−キナーゼ阻害剤
|